Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Wang, Dan ^a   Liu, Yuhuan ^a   Han, Jie ^a   Zai, Dongxia ^a   Ji, Mei ^a   Cheng, Wen ^a   Xu, Ling ^a   Yang, Luxi ^a   He, Miaoxia ^a   Ni, Jian ^b   Cai, Zailong ^a   Yu, Chaoqin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; PUERARIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN; VIMENTIN; ESTROGEN; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; TIMP1 PROTEIN, HUMAN; VASCULOTROPIN A; VASODILATOR AGENT; VEGFA PROTEIN, HUMAN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL INVASION; CELL ISOLATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOMETRIOSIS; FLUOROIMMUNOASSAY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN SYNTHESIS INHIBITION; STROMA CELL; VASCULARIZATION; WESTERN BLOTTING; ANIMAL; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENDOMETRIUM; ENZYME IMMUNOASSAY; FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; ISOFLAVONES; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ESTROGEN; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATOR AGENTS;

EID: 80052860607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025011     Document Type: Article

References (36)

1. Olive DL, Schwartz LB, (1993) Endometriosis. N Engl J Med 328: 1759-1769.
2. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG, (1997) Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99: 2851-2857.
3. Collette T, Maheux R, Mailloux J, Akoum A, (2006) Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 21: 3059-3067.
4. Bruner KL, Eisenberg E, Gorstein F, Osteen KG, (1999) Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 64: 648-653.
5. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81: 3112-3118.
6. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M, (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13: 1686-1690.
7. Nasu K, Nishida M, Ueda T, Takai N, Bing S, et al. (2005) Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis. Mol Hum Reprod 11: 817-823.
8. Bergqvist A, SCANDET Group (2000) A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol 14: 425-432.
9. Boonchird C, Mahapanichkul T, Cherdshewasart W, (2010) Differential binding with ERalpha and ERbeta of the phytoestrogen-rich plant Pueraria mirifica. Braz J Med Biol Res 43: 195-200.
10. Hwang YP, Jeong HG, (2008) Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 233: 371-381.
11. Katzenellenbogen BS, Ferguson ER, Lan NC, (1997) Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action. Endocrinology 100: 1252-1259.
12. Folman Y, Pope GS, (1966) The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34: 215-225.
13. Wang C, Kurzer MS, (1997) Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28: 236-247.
14. Collins BM, McLachlan JA, Arnold SF, (1997) The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 62 (4): 365-372.
15. Overstreet DH, Keung WM, Rezvani AH, Massi M, Lee DY, (2003) Herbal remedies for alcoholism: promises and possible pitfalls. Alcohol Clin Exp Res 27: 177-185.
16. Xu X, Zhang S, Zhang L, Yan W, Zheng X, (2005) The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med 71: 585-591.
17. Wang Y, Yu J, Luo X, Wang X, Li M, et al. (2010) Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells. Cell Mol Immunol 7: 51-60.
18. Szamatowicz J, Laudański P, Tomaszewska I, (2002) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod 17: 284-288.
19. Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N, (2008) Matrix metalloproteinases 2 and 9, E-cadnerin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reprod Biol 139: 226-232.
20. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, et al. (2008) Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44: 439-449.
21. Han YJ, Kim HN, Yoon JK, Yi SY, Moon HS, et al. (2009) Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis. Fertil Steril 91: 2324-2330.
22. Yu C, Li Y, Chen H, Yang S, Xie G, (2008) Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity. Food Chem Toxicol 46: 3671-3676.
23. Li YW, Cai ZL, Shen W, Yang SS, Yu CQ, (2008) Regulation of aromatase P450 expression by puerarin in endometrial cell line RL95-2. Zhong Xi Yi Jie He Xue Bao 6: 1017-1023.
24. Rice S, Mason HD, Whitehead SA, (2006) Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulose-luteal cell. J Steroid Biochem Mol Biol 101: 216-225.
25. Nap AW, Groothuis PG, Demir AY, Maas JW, Dunselman GA, et al. (2003) Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod 18: 30-34.
26. Sillem M, Hahn U, Coddington CC 3rd, Gordon K, Runnebaum B, et al. (1996) Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis. Fertil Steril 66: 468-473.
27. Moromizato Y, Stechschulte S, Miyamoto K, Murata T, Tsujikawa A, et al. (2000) CD18 and ICAM-1-dependent corneal neovascularization and Inflammation after limbal Injury. Am J Pathol 157: 1277-1281.
28. Defrère S, Van Langendonckt A, Moulin P, Befahy P, Gonzalez D, et al. (2005) Human endometrial epithelial cells (EEC) constitutively express more intercellular adhesion molecule(ICAM)-1 than endometrial stromal cells (ESC) in culture. Am J Reprod Immunol 54: 5-12.
29. Lessey BA, (2000) Medical management of endometriosis and infertility. Fertil Steril 73: 1089-1096.
30. Rice VM, (2002) Conventional medical therapies for endometriosis. Ann N Y Acad Sci 955: 343-352.
31. Valle RF, Sciarra JJ, (2003) Endometriosis: treatment strategies. Ann N Y Acad Sci 997: 229-239.
32. Olive DL, Lindheim SR, Pritts EA, (2004) New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 18: 319-328.
33. Practice Committee of the American Society for Reproductive Medicine (2004) Endometriosis and infertility. Fertil Steril 81: 1441-1446.
34. Bergqvist A, SCANDET Group (2000) A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol 14: 425-432.
35. Wang Y, Yu J, Luo X, Li M, Wang L, et al. (2010) Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells. Cell Mol Immunol 7: 51-60.
36. Richardson M, Sing G, (2003) Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr Drug Targets Cardiovasc Haematol Disord 3: 155-185.